Clik here to view.
Journey to the Center of the Brain
That’s the potential of a revolutionary new technology known as Deep Transcranial Magnetic Stimulation, or Deep TMS, being developed by Israel-based Brainsway (TASE:BRIN). Brainsway has a world-wide...
View ArticleClik here to view.
Transition Therapeutics posts positive TT-401 results
Transition Therapeutics (NASDAQ:TTHI; TSX:TTH) has announced positive results of a five-week, proof-of-concept clinical study of TT-401 in Type 2 diabetic and obese non-diabetic subjects. In the...
View ArticleClik here to view.
Roth ups EnteroMedics price target
Roth Capital Partners has raised its price target for “buy-rated” EnteroMedics (NASDAQ:ETRM) to $3 from $2 after the company announced positive 18-month data for its ReCharge pivotal trial that...
View ArticleClik here to view.
M Pharma advancing technologies for obesity and diabetes
M Pharmaceutical (OTCQB:MPHMF; CSE:MQ; FWB:T3F1.F) is advancing a family of biomedical technologies to manage obesity – TriMeo and TriMtec – and eMosquito to manage diabetes. Dr. Martin Mintchev “All...
View Article
